Health care stocks were moderately higher Friday afternoon, with the NYSE Health Care Index rising 0.6% and the Health Care Select Sector SPDR Fund (XLV)...
Health care stocks were moderately higher Friday afternoon, with the NYSE Health Care Index rising 0.4% and the Health Care Select Sector SPDR Fund (XLV)...
AnaptysBio (ANAB) said Friday its board has approved a share repurchase plan for up to $50 million worth of its common shares. The buyback program is...
AnaptysBio (ANAB) has an average rating of hold and price targets ranging from $23 to $44, according to analysts polled by Capital IQ. (MT Newswires covers...
| Address | 10770 Wateridge Circle San Diego, California 92121-5801 |
| Phone | +1.858.362.6295 |
| Number of Employees | 78 |
| Recent SEC Filing | 03/01/2023 S-8 |
| President, Chief Executive Officer & Director | Daniel R. Faga |
| Chief Operating Officer & General Counsel | Eric J. Loumeau |
| Chief Financial Officer | Dennis M. Mulroy |
| Chief Medical Officer | Paul F. Lizzul |
| Price Open | $21.60 |
| Previous Close | $21.63 |
| 52 Week Range | $18.20 - 32.44 |
| Market Capitalization | $597.7 M |
| Shares Outstanding | 27.9 M |
| Sector | Health Technology |
| Industry | Biotechnology | Next Earnings Announcement | 05/03/2023 |
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
| Price / Earnings | N/A |
| Earnings per Share | -$4.58 |
| Beta vs. S&P 500 | N/A |
| Revenue | $5.0 M |
| Net Profit Margin | -1,251.33% |
| Return on Equity | -43.83% |
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |
